Clinician to CEO : Export Your Medical Device With Confidence By Overcoming Go To Market Roadblocks For Medtech Growth

Your medical device has regulatory approval, clinical evidence and manufacturing in place but does that actually mean customers are ready to buy it?This doesn't diagnose their problem. It challenges the assumption that the three green ticks automatically equal commercial readiness.A MedTech product can be completely ready to launch and still not be commercially ready to sell. Before spending heavily on salespeople, distributors, exhibitions or new export markets, you need to know whether customers have genuine demand, how your medical device actually gets bought, and what could make adoption harder than expected. In this episode, Hakeem explains how to assess your commercial readiness before scaling a go-to-market strategy that may not yet work.In this episode you'll discover:How to distinguish genuine customer demand from positive feedback and interest before investing heavily in commercialisation.Why understanding the complete buying pathway—from clinicians and other decision-makers to evidence, procurement and budgets—is critical to turning interest into revenue.How to identify adoption friction and stress-test your go-to-market model before adding more salespeople, distributors or export markets.Listen now to discover whether your MedTech product is genuinely ready to sell—and what you need to fix before investing more money in commercialisation, adoption and international growth.Message me via DM on LinkedinTake the CPI Quiz to see how commercially ready your product isThis podcast is for clinicians feeling stuck in turning medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, and to scale up their international sales in MedTech.

What if spending more money on sales isn't actually the fastest way to grow your MedTech business?For clinician founders looking to commercialise and export a medical device internationally, growing a MedTech business takes more than regulatory approval, investment and an expensive sales team. If the market doesn't understand the problem your product solves or have a reason to change, adding salespeople can simply increase your burn rate without increasing adoption. In this episode, Hakeem speaks with international growth and commercialisation consultant Craig T. Ingram about creating demand before launch, entering new export markets and building a commercial model capable of sustainable international growth.By listening you'll discover:Why MedTech commercialisation needs to start long before regulatory approval and product launch.Why spending heavily on salespeople isn't the same as building a market—and what needs to happen first to create demand.Why proving your commercial model, controlling your burn rate and executing consistently can be more important than trying to scale quickly.ActionListen now to discover how to grow your MedTech business by creating demand first, spending your commercial resources more intelligently and building a model that can scale sustainably.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

If a great export distributor had four MedTech products to choose from today, why would they choose yours?MedTech manufacturers spend a lot of time asking whether a distributor is capable of selling their product. But there's another question that's just as important: why should a good distributor choose you? Taking on your product means investing their sales time, clinical resources, customer relationships, marketing activity and reputation. In this episode, Hakeem unpacks a real decision with experienced GCC distributor Sameh Salama to reveal what good export distributors actually look for before deciding whether a MedTech product represents a genuine commercial opportunity. Listen to this episode to discover:Why strong clinical evidence matters to export distributors but isn't enough on its own to create a compelling commercial opportunity.What good distributors assess before agreeing to represent your MedTech product—and why a distributor who challenges you can actually be a very positive sign.Why successful MedTech commercialisation and export depends on the manufacturer and distributor working together to create demand, rather than expecting the distributor to build the market alone. Listen now to discover what good export distributors really look for and how to make your MedTech product a commercial opportunity they'll want to invest their time, resources and relationships in.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

If your MedTech product isn't selling as quickly as expected, are more salespeople really going to fix the problem?When a MedTech launch underperforms, hiring more salespeople, recruiting another distributor or attending more exhibitions can feel like the obvious answer. But if the market hasn't been prepared and customers don't yet see a compelling reason to change, more sales activity won't solve the underlying problem. In this episode, Hakeem explains why successful MedTech commercialisation and export starts long before launch—and why understanding and preparing your market can save you from trying to force adoption later.In this episode you'll discover:Why MedTech commercialisation should begin months before your product launches, rather than after regulatory approval.Why adding salespeople or export distributors won't fix a market that isn't ready to adopt your product.How understanding what keeps your customers awake at night can help you create demand, prepare the market and accelerate adoption.ActionListen now to learn how to prepare your market before you commercialise or export your MedTech product, so your sales team can convert demand rather than having to create it from scratch.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Is your MedTech product genuinely ready for commercialisation and export, or are you simply working through a checklist?Many MedTech founders believe that regulatory approval, clinical evidence, patents, and distributor interest mean they're ready for commercial success. But commercial readiness is about far more than ticking boxes. In this episode, Hakeem explains why successful commercialisation depends on multiple factors working together and introduces a structured way of assessing whether your MedTech product is truly ready for commercialisation and export before investing significant time and money.In this episode, you'll discover:Why regulatory approval, clinical evidence, and distributor interest don't automatically mean your MedTech product is commercially ready.The key questions that reveal whether your product is ready for commercialisation, adoption, and export.How to identify commercial risks early so you can make better investment, launch, and export decisions with greater confidence.Listen now to learn how to assess your MedTech product's commercial readiness, strengthen your commercialisation strategy, and export with greater confidence.Message me with CPI on Linkedin, to really see if your product is ready for commercialisationThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

If your MedTech product already has strong clinical evidence, why are clinicians still hesitant to adopt it?Many MedTech founders assume that if adoption is slow, the answer is to generate more clinical evidence. But from a clinician's perspective, the real barrier is often confidence rather than proof. In this episode, Hakeem unpacks a real commercial decision with consultant cardiologist Dr Tang Wan, revealing why trusted local reference sites can have a greater influence on adoption than another published study, and how founders should use this insight to strengthen their commercialisation strategy.In this episode, you'll discover:Why clinicians don't always need more clinical evidence before adopting a new MedTech product.How trusted local reference sites reduce the perceived risk of adopting an innovative medical device.Why your first customers can become your most influential commercial asset by accelerating future adoption.Listen now to discover why trusted reference sites often matter more than additional clinical evidence and learn how to use your early customers to drive wider MedTech adoption.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Have you ruled out Japan because you've been told it's too difficult, too expensive, or takes too long to enter?Many MedTech companies overlook Japan because they assume the regulatory process is complex, the culture is difficult to navigate, and market entry requires significant resources. But the reality has changed. In this episode, Japan market expert Curt Jennewine explains why many of the traditional barriers are no longer as challenging as they once were and what MedTech companies need to understand before entering one of the world's largest healthcare markets.Listeners will discover:Why success in Europe or the US doesn't automatically guarantee success in JapanHow Japan's regulatory, reimbursement, and distributor landscape has evolved in recent yearsWhat MedTech companies should look for when selecting partners and building a successful export strategy for JapanPlay this episode now to discover whether Japan could be a faster, more accessible, and more commercially attractive export market than you think.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.